Glucotrack signs up to $20M equity purchase agreement with Sixth Borough Capital Fund

Glucotrack, Inc.

Investor committed to buy up to $20M of common stock over 24 months at company's discretion.
Regular purchase price at 97% of VWAP; add-on/intraday at 95% of VWAP.
Commitment fee of 1.5% ($300k) payable in cash, stock, or warrants on Commencement Date.
Exchange cap of 179,792 shares (19.99% of outstanding) unless stockholder approval or price condition met.
Investor prohibited from short sales; company may terminate pact with 1 business day notice.

Key facts

Extracted from this filing and checked against the source text.

Equity Issuances SEC 8-K Item 3.02/3.03 confidence 0.9

Glucotrack, Inc. issued common stock to Sixth Borough Capital Fund, LP for up to $20.0 million of the Company’s common stock.

Security: common stock
Purchaser: Sixth Borough Capital Fund, LP
Consideration: up to $20.0 million of the Company’s common stock

Exact text from the filing

On September 11, 2025, Glucotrack, Inc. (the “ Company ”) entered into a purchase agreement (the “ Purchase Agreement ”) and a registration rights agreement (the “ Registration Rights Agreement ”), with Sixth Borough Capital Fund, LP (the “ Investor ”), pursuant to which the Investor has committed to purchase up to $20.0 million of the Company’s common stock, par value $0.001 per share (the “ Common Stock ”)

View on SEC.gov

Browse all equity issuances →

Glucotrack, Inc. filing history →

Source: SEC EDGAR

accession 0001493152-25-013094

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.